Yayın:
Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits

dc.contributor.authorSozer, Volkan
dc.date.accessioned2026-06-27T13:42:06Z
dc.date.issued2015
dc.description.abstractThe aim of this study was to investigate the effects of a high-cholesterol diet in the presence and absence of statin on Cu-Zn-superoxide dismutase (Cu, Zn-SOD), malondialdehyde (MDA), protein carbonyl (PCO), and nitric oxide (NO) of blood and heart tissue, the antioxidant activity of serum paraoxonase-1 (PON-1), and on the blood lipid profile of rabbits. The animals were divided into four groups each of which included 10 rabbits. Rabbits in group 1 received a regular rabbit chow diet (normal diet) for 8 weeks; those in group 2 received atorvastatin (0.3 mg atorvastatin per day/kg body weight) for 8 weeks; those in group 3 received high-cholesterol diet for 8 weeks; and those in group 4 received high-cholesterol diet for 4 weeks, a high-cholesterol diet + atorvastatin (0.3 mg atorvastatin per day/kg body weight) for 8 weeks. The parameters were measured by spectrophotometric methods. As expected, the atherogenic diet caused a pronounced increase in lipid profile (not HDL) parameters. Rabbits in group 3 showed higher PCO, MDA, and NO levels in circulating and heart tissue compared to the rabbits in group 1. Atorvastatin has prevented or limited LDL oxidation and has showed constitutively beneficial effects in group 4. Increased LDL-C, PCO, MDA, and NO levels leading to decreasing PON-1 activity thus create a predisposition to atherogenesis in this model. But atorvastatin administration partly ameliorated oxidative damage in heart injury of hypercholesterolemic rabbits. Atorvastatin which functions as a potent antioxidant agent may inhibit this LDL-C oxidation by increasing PON-1 activity in atherogenesis.en
dc.description.urihttps://doi.org/10.1111/fcp.12144
dc.identifier.doi10.1111/fcp.12144
dc.identifier.eissn1472-8206
dc.identifier.endpage566
dc.identifier.issn0767-3981
dc.identifier.issue6
dc.identifier.pubmed26456720
dc.identifier.startpage558
dc.identifier.urihttps://hdl.handle.net/20.500.14981/54220
dc.identifier.volume29
dc.identifier.wos000368233200006
dc.language.isoeng
dc.publisherWILEY-BLACKWELL
dc.relation.ispartofFUNDAMENTAL & CLINICAL PHARMACOLOGY
dc.subjectatorvastatin
dc.subjecthypercholesterolemia
dc.subjectmalondialdehyde
dc.subjectparaoxonase-1
dc.subjectprotein carbonyl
dc.subjectCHOLESTEROL-FED RABBITS
dc.subjectNITRIC-OXIDE CONCENTRATION
dc.subjectSHORT-TERM TREATMENT
dc.subjectC-REACTIVE PROTEIN
dc.subjectSUPEROXIDE-DISMUTASE
dc.subjectPARAOXONASE ACTIVITY
dc.subjectATORVASTATIN THERAPY
dc.subjectDENSITY-LIPOPROTEIN
dc.subjectDNA-DAMAGE
dc.subjectHYPERLIPIDEMIC RABBITS
dc.subjectPharmacology & Pharmacy
dc.titleAmeliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar